ADD medications
 

NeuroResearch Clinics, Inc.

 AMA Category 1  
 Continuing Medical Education 
 
HOME PAGE
 
The Diseases
 
Attention Deficit ADD
Anxiety / Panic Attacks
Alzheimer's Dementia
Depression
Suicide
Fibromyalgia
Insomnia
Migraine headaches
Parkinson's Disease
Trichotillomania
Obsessive Compulsive Disorder-OCD
 
Antidepressants
Brain Damage
Neurotransmitter Depletion
Protocols
Side Effects
neurotransmitter testing
 
University Writings About NeuroResearch Clinics
 
Neurotoxins
Technical Guide
Narrated Slide Shows
Public Interviews
Med Ed Web Site
DBS Labs Web Site
Faba Bean Warning
Webinars
Sitemap
Contact Us
 
Phoenix, AZ at Sunrise photo by Marty L. Hinz, MD 
 ADD medications
ADD medications
ADD medications
Contact us or find a caregiver using this approach.
 

ADD medications

 
Written by: Marty L. Hinz, MD
President Clinical Research
NeuroResearch Clinics, Inc.
Cape Coral, Florida USA Research Office 
  
 

  The pages of this web site article contain an in depth discussion of a new and highly effective neurotransmitter approach to treating without the use of ADD medications in clinics. This treatment without drugs or drug side effects was developed by NeuroResearch Clinics. While on the surface this approach with no ADD medications may appear similar to treatment attempted by others in the past, it is differentiated from other approaches by the high degree of effectiveness achieved and the unique way the individual components are used. This approach with no ADD medications was developed by medical doctors caring for medical patients in their clinics while data basing treatment results. If you need assistance in finding a care giver using the NeuroResearch Clinics approach in treatment without ADD medications, we can help.

ADD medications

  In the world of ADD medications for attention deficit (ADD) there are two groups of drugs prescribed by doctors:

  • Amphetamines

  • Reuptake Inhibitors

  Amphetamines are ADD medications that have multiple chemical properties, they are reuptake inhibitors and they are neurotoxins (cause permanent brain damage). Of concern with prescription drugs is:

  • Amphetamines are neurotoxic. (Adderall, Vyvanse)

  • Reuptake inhibitors deplete neurotransmitters (Concerta, Ritalin, Strattera, Focalin)

  • drugs side effects (see drugs linked below)

ADD medications

  The ADD medications known as "reuptake inhibitors" include Concerta, Ritalin, Strattera and Focalin. These ADD medications under normal conditions deplete neurotransmitters. The reuptake inhibitor ADD medications share the problem that they quit working during treatment at some point in time. The reason that the ADD medications quits working is because drugs that with neurotransmitters do not work if there is not enough neurotransmitters to work with. When the ADD medications quit working it is because neurotransmitter levels have been depleted, by the drugs, to levels that are too low to keep the drugs working. When one of these drugs quit working the standard approach in medicine is to:

  • increase the drugs dosing

  • add a second drugs

  • start a new drugs

  Each of the treatment options above, in using ADD medications in treatment, only serve to deplete neurotransmitter levels in the brain further making the cause of the problem worse. In using ADD medications in treatment they make the cause of the problem worse, "low neurotransmitter levels". With severe depletion of neurotransmitters the risk of suicide develops. All the ADD medications used to treat depression and attention deficit (ADD) carries a suicide warning in their prescribing information. For an in depth discussion of how the ADD medications deplete neurotransmitters and induces suicide risk see the links below.

Amphetamines

  ADD medications known as Adderall and Vyvanse are amphetamines. All amphetamines are "neurotoxins"' known to cause permanent brain damage. So what does brain damage from amphetamine ADD medications look like?  In the upper left column of this web page is a link titled "The Diseases". Click on it and it will take you to a list of neurotransmitter diseases. These are the diseases that can develop on a chronic basis with ADD medications use. These diseases usually do not develop while the amphetamine is being taken instead they develop 3 to 5 years after amphetamine ingestion stops.

The NeuroResearch Approach

  Unlike ADD medications used in treatment, the approach of NeuroResearch Clinics uses nutrients that build neurotransmitters to levels needed for relief of symptoms. The use of nutrients with neurotransmitter testing is a powerful tool and a unique option to ADD medications.

  Its no secret, NeuroResearch Clinics uses the nutrients 5-HTP, tyrosine, levodopa, and cysteine instead of ADD medications in order to get these results. Proper use of these simple ingredients in medical treatment is not simple. From time to time a patient will say, "Why do I want to take that, I can go to a health food store and buy it?" People off the street buying in a health food store is like going to an art store and buying a bunch of oil paints then going home and expecting to paint like a mater artist even though there was no previous painting experience. These nutrients have tremendous potential due to their chemical properties. This potential is only fully realized in the hands of the trained professional using neurotransmitter testing. Treatment is not just giving a nutrient pill, it is the whole medical management approach doctors are trained in to insure that that treatment is on track in order to get symptoms under control.

The Peer Reviewed Research of NeuroResearch Clinics

  The ADD medications research findings of NeuroResearch Clinics have not been ignored. The University of Minnesota Medical School is writing a series of papers on the neurotransmitter testing research of NeuroResearch Clinics. The first of a series of papers by University of Minnesota Medical School based on the neurotransmitter testing research of NeuroResearch was published in "NeuroPsychiatric Disease and Treatment" May 1, 2009. Ingrid Kohlstadt, MD of Johns Hopkins in her new medical text book released February 7, 2009 included a chapter on depression written by Marty L. Hinz, MD  President Clinical Research NeuroResearch Clinics outlining in depth the proper use of amino acids and neurotransmitter testing in treatment of depression. 

University of Minnesota Medical School neurotransmitter testing paper on the research of NeuroResearch Clinics.

 

The medical text book chapter on depression written by Marty L. Hinz, MD-Ingrid Kohlstadt, MD editor-Johns Hopkins released February, 7, 2009

ADD medications
ADD home page

ADD Testimonials

ADD treatment

ADD natural remedies

ADD medications

ADD symptoms

ADD diagnosis

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
How attention deficit drugs deplete neurotransmitters 
  
How attention deficit drugs cause suicide risk 
  
ADD medications external web site link 
 ADD medications research
Attention Deficit Medication Prescribing InformationADD medications research
ADD medications Adderall (amphetamine) 
ADD medications Vyvanse (amphetamine) 
ADD medications Concerta (reuptake inhibitor) 
ADD medications Ritalin (reuptake inhibitor) 
ADD medications Strattera (reuptake inhibitor) 
  

criteria

If you need a medical speaker for AMA Category I CME call NeuroResearch Clinics, Inc.
NeuroResearch Clinics, Inc. only deals with and provides information to licensed health care professionals.
 
ADD medications
 
keyz keyb
 
ADD medications